LJAC
ASND icon

L.J. Altfest & Co’s Ascendis Pharma A/S ASND Stock Holding History

L.J. Altfest & Co’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,756
Closed -$588K – 336
2025
Q4 		$588K Buy
2,756
+586
+27% +$121K 0.06% 199
2025
Q3 		$431K Sell
2,170
-4
-0.2% -$746 0.05% 243
2025
Q2 		$375K Buy
2,174
+63
+3% +$10.3K 0.04% 256
2025
Q1 		$329K Buy
+2,111
New +$302K 0.04% 260

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

L.J. Altfest & Co's ASND Position: Q1 2026 in Review

L.J. Altfest & Co sold out of Ascendis Pharma A/S (ASND) in Q1 2026, closing a stake of 2,756 shares — an estimated $588K sold.

L.J. Altfest & Co first reported a position in ASND in Q1 2025 and held it in 4 quarters. The position peaked at $588K in Q4 2025. 274 funds tracked by Wall St. Rank hold ASND as of Q1 2026.

  • L.J. Altfest & Co reported no remaining Ascendis Pharma A/S position as of Q1 2026 after selling out during the quarter.
  • L.J. Altfest & Co sold 2,756 Ascendis Pharma A/S shares in Q1 2026, an estimated $588K.
  • L.J. Altfest & Co first reported a position in Ascendis Pharma A/S in Q1 2025 and held it in 4 quarters.
  • L.J. Altfest & Co's Ascendis Pharma A/S position peaked at $588K in Q4 2025.
  • 274 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q1 2026.

Based on L.J. Altfest & Co's 13F filing for Q1 2026, filed 28 Apr 2026.